1. 566C80: a broad spectrum anti-infective agent with activity against malaria and opportunistic infections in IDS patients;Hudson;Drugs Exp Clin Res.,1991
2. Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4′ chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone (566C80);Fry;Biochem Pharmacol,1992
3. Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malarial parasite;Srivastava;J Biol Chem,1997
4. Vaidya, A. B. Mitochondrial physiology as a target for atovaquone and other antimalarials. Sherman, I. W. Malaria: Parasite biology, pathogenesis, and protection. Washington, DC, ASM Press, 1998, 355, 368
5. Evaluation of atovaquone in the treatment of patients with uncomplicated Plasmodium falciparum malaria;Chiodini;J Antimicrob Chemother,1995